Most recently, it's been discovered that conolidine and the above mentioned derivatives act on the atypical chemokine receptor 3 (ACKR3. Expressed in comparable areas as classical opioid receptors, it binds to some big range of endogenous opioids. Compared with most opioid receptors, this receptor acts to be a scavenger https://paulq812czy3.wikissl.com/user